positive Studiendaten
https://www.thestreet.com/investing/...hilia-treatment-trial-14914637
~130 Mio. $ Offering
https://seekingalpha.com/news/...amo-6-percent-pricing-stock-offering
gute Phase 1/2 SB-525 hemophilia A Studienergebnisse
https://xconomy.com/san-francisco/2019/07/08/...ia-gene-therapy-race/
https://www.pharmaceutical-business-review.com/...o-hemophilia-study/